The Pharmacy Times® COVID-19 Resource Center is a comprehensive resource for clinical news and expert insights on COVID-19, an infectious disease caused by the SARS-CoV-2 virus, including vaccine information and treatments for the disease.
September 15th 2025
Pharmacists face challenges as recent federal policy changes threaten their expanded roles in vaccination and public health, impacting patient access to care.
September 11th 2025
According to phase 3 trial results, Pfizer-BioNTech’s LP.8.1-adapted COVID-19 vaccine demonstrated significant immune responses in older adults and individuals at high risk for severe COVID-19.
September 4th 2025
Azelastine, commonly used in nasal sprays to combat allergies, was found to reduce the incidence of SARS-CoV-2 among healthy controls in a phase 2 trial.
August 28th 2025
COVID-19 vaccination significantly reduces the risk of asthma and other airway inflammatory diseases, offering vital protection against respiratory complications.
August 27th 2025
The FDA's approvals follow new COVID-19 guidance announced by the commissioner of the agency in May 2025, focusing future approvals on older adults.
NCPA Hosts Tele-Conference to Discuss Importance of Pharmacists During COVID-19 Pandemic
March 27th 2020More than 1800 members registered for the town hall-style meeting, during which Rep. Buddy Carter (R-GA), a pharmacist and congressman, briefed attendees about emergency relief efforts currently in development by policymakers, efforts to address pharmacy direct and indirect remuneration (DIR) fees, and other key issues.
Read More
Potential COVID-19 Treatment Granted Orphan Drug Status
March 25th 2020While remdesivir is not FDA-approved to treat the novel coronavirus, the orphan drug status would provide 7 years of exclusive marketing in the United States and tax credits on research and development costs once the drug was approved.
Read More
FDA Takes Action to Increase US Supplies of PPE, Devices to Combat COVID-19
March 25th 2020The FDA released a statement on taking action to increase US supplies to support the response to the coronavirus disease 2019 by providing instructions to manufacturers importing personal protective equipment and other devices.
Read More
AI Turns Coughing Sounds into Health Data for Flu, Pandemic Forecasting
March 25th 2020The new edge-computing platform may expand the arsenal of health surveillance tools used to forecast seasonal flu and other viral respiratory outbreaks, such as COVID-19 or severe acute respiratory syndrome.
Read More
COVID-19 Workers to Be Provided With Training to Protect Own Health
March 25th 2020The program will award grants for training and development of educational resources for employees in high risk occupations who serve the public during emergencies and who need skills to protect their own health.
Read More
Pennsylvania Lifts Regulation on Pharmacies for Telemedicine, Receiving Goods from Out-of-State
March 24th 2020Pennsylvania Governor Tom Wolf’s administration has decided that in-state and out-of-state health care providers can treat patients via telemedicine during the coronavirus disease 2019 pandemic.
Read More
US Pharmacopeia Providing Support to COVID-19 Vaccine, Antiviral Drug Developers
March 23rd 2020The US Pharmacopeia (USP) is providing free technical assistance to developers of antiviral drugs and vaccines that will support the public health response to the coronavirus disease 2019 (COVID-19) pandemic.
Read More
259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831